首页|全外显子组测序对性发育异常患者的分子遗传学病因分析

全外显子组测序对性发育异常患者的分子遗传学病因分析

扫码查看
目的 通过全外显子组测序(WES)技术分析性发育异常(DSD)患者的分子遗传学病因,以加深对DSD致病机制的认识。方法 收集2008年3月-2021年8月于云南省第一人民医院就诊的60例DSD患者的临床资料进行回顾性分析,并对其中1个先证者进行家系研究。提取所有患者的外周血基因组DNA进行WES测序分析,WES结果利用SAMtools软件、单核苷酸多态性(SNP)数据库、InDel数据库进行SNP和InDel检测;采用ExomeDepth进行外显子水平的拷贝数变异(CNV)检测;应用PolyPhen-2、Mutation taster、PyMol软件进行突变的有害性预测,并采用Sanger进行测序验证。结果 60例DSD患者中,22例为46,XX DSD,38例为46,XY DSD。22例46,XX DSD患者中14例存在SRY基因;在另外8例患者和其中1个先证者家系中,2例患者的NR5A1、PROKR2和ANOS1基因发生单核苷酸变异(SNV),4例患者中的CYP21A2基因发生CNV,其中CYP21A2 EX1 Dup已有该变异的相关致病性报道,其余3个CNV为意义未明的变异,2例未检出与DSD相关的基因突变位点。38例46,XY DSD患者WES分析结果中,14例中检出了10个致病或疑似致病变异位点,包括SRY、AR、SRD5A2、CYP17A1、NR5A1等5个基因;5例中检出CYP21A2、AKR1C2、CBX2、NR5A1基因的5个疑似致病的CNV,其中3个微缺失,2个微重复。WES结果中NR5A1(c。722G>T、c。48C>G)、ANOS1 c。564A>T变异为首次报道的位点,在检出的CNV中,CYP21A2 EX1 Dup在相关数据库中有致病性的报道,其余未见报道。结论 WES技术的应用提高了对DSD的诊断能力,拓展了现有的DSD相关致病基因突变谱数据,丰富了对DSD致病机制的认识,可为开展遗传咨询提供帮助。
Analysis on genetic etiology of disorders of sex development using whole exome sequencing
Objective To elucidate the molecular genetic etiology of patients with disorders of sex development(DSD)using whole exome sequencing(WES),thereby enhancing our understanding of the underlying mechanisms of sexual development abnormalities.Methods Retrospective analysis was conducted on clinical data of 60 DSD patients diagnosed in the First People's Hospital of Yunnan Province between March 2008 and August 2021,with an additional family study for one proband.Genomic DNA was extracted from patients for WES analysis.Single nucleotide polymorphism(SNP)and insertions/deletion(InDel)tests were identified using SAMtools software in conjunction with established SNP and InDel databases.Copy number variations(CNVs)at the exon level were detected using ExomeDepth,while the potential pathogenicity of mutations was predicted with PolyPhen-2,Mutation taster and PyMol software,with Sanger sequencing employed for confirmation.Results The study included 22 patients with 46,XX DSD and 38 with 46,XY DSD.Among the 46,XX DSD patients,the SRY gene was detected in 14 patients.In the remaining 8 patients and a proband's families,single nucleotide site variations(SNVs)of NR5A1,PROKR2 and ANOS1 genes were identified in 2 patients,and CNVs in CYP21A2 gene were found in 4 patients.The pathogenicity of CYP21A2 EX1 Dup has been previously reported,while the remaining 3 CNVs were of uncertain significance,and no DSD-related mutations were detected in 2 patients.In the WES analysis of 46,XY DSD patients,10 pathogenic or likely pathogenic SNVs across 5 genes(SRY,AR,SRD5A2,CYP17A1,and NR5A1)were identified in 14 patients.Additionally,5 likely pathogenic CNVs involving the CYP21A2,AKR1C2,CBX2,and NR5A1 genes were detected in 5 patients,comprising 3 deletions and 2 duplications.Novel SNVs in NR5A1(c.722G>T,c.48C>G)and ANOS1 c.564A>T were identified,with no prior reports in relevant databases.The pathogenicity of CYP21A2 EX1 Dup is documented in related databases,while the remaining CNVs have not been previously reported.Conclusion The utilization of WES technology has enhanced the diagnostic potential for DSD,broadened the spectrum of known DSD-related gene mutations,and deepened our comprehension of DSD pathogenesis,offering valuable support for genetic counseling.

disorders of sex developmentwhole exome sequencingdiagnosisheterogeneity

吴柳娇、靳婵婵、朱姝、黄文明、叶建宏、吕涛、朱宝生、贺静

展开 >

昆明理工大学医学院,云南昆明 650500

云南省第一人民医院医学遗传科/国家卫生健康委西部孕前优生重点实验室,云南昆明 650500

性发育异常 全外显子组测序 诊断 异质性

国家自然科学基金云南省技术创新人才培养项目

818600302019HB071

2024

解放军医学杂志
人民军医出版社

解放军医学杂志

CSTPCD北大核心
影响因子:1.644
ISSN:0577-7402
年,卷(期):2024.49(5)